Role of nitric oxide in management of acute respiratory distress syndrome
The current mortality rate of patients suffering from acute respiratory distress syndrome (ARDS) is between 45% and 92%, with most dying within the first two weeks of the illness. In an effort to combat such an alarmingly high mortality rate, various treatment therapies such as...
Main Authors: | Akmal A, Hasan Mohd |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2008-01-01
|
Series: | Annals of Thoracic Medicine |
Subjects: | |
Online Access: | http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2008;volume=3;issue=3;spage=100;epage=103;aulast=Akmal |
Similar Items
-
Role of Inhaled Nitric Oxide in the Management of Pediatric Acute Respiratory Distress Syndrome
by: Juliette Lucinda Hunt, et al.
Published: (2016-08-01) -
Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes
by: Armand Mekontso Dessap, et al.
Published: (2023-06-01) -
Acute Respiratory Distress Syndrome (ARDS) After Nitric Acid Inhalation
by: Gülay Kır, et al.
Published: (2014-12-01) -
Acute respiratory distress syndrome: How to optimize oxygen transport and to improve prognosis
by: V A Shtabnitskiĭ, et al.
Published: (2014-11-01) -
Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19
by: Driss Laghlam, et al.
Published: (2021-07-01)